Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Gains from Sales and Divestitures (2019 - 2023)

Historic Gains from Sales and Divestitures for INVO Fertility (IVF) over the last 5 years, with Q3 2023 value amounting to $16505.0.

  • INVO Fertility's Gains from Sales and Divestitures fell 8790.9% to $16505.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $16505.0, marking a year-over-year decrease of 8790.9%. This contributed to the annual value of $143174.0 for FY2022, which is 3016.96% down from last year.
  • INVO Fertility's Gains from Sales and Divestitures amounted to $16505.0 in Q3 2023, which was down 8790.9% from $16505.0 recorded in Q2 2023.
  • INVO Fertility's Gains from Sales and Divestitures' 5-year high stood at $1.2 million during Q1 2020, with a 5-year trough of $2083.0 in Q4 2019.
  • For the 5-year period, INVO Fertility's Gains from Sales and Divestitures averaged around $147945.1, with its median value being $71312.5 (2020).
  • As far as peak fluctuations go, INVO Fertility's Gains from Sales and Divestitures soared by 297349.98% in 2020, and later plummeted by 9788.88% in 2021.
  • Over the past 5 years, INVO Fertility's Gains from Sales and Divestitures (Quarter) stood at $2083.0 in 2019, then soared by 2973.5% to $64021.0 in 2020, then skyrocketed by 220.26% to $205031.0 in 2021, then crashed by 30.17% to $143174.0 in 2022, then plummeted by 88.47% to $16505.0 in 2023.
  • Its Gains from Sales and Divestitures was $16505.0 in Q3 2023, compared to $16505.0 in Q2 2023 and $179798.0 in Q1 2023.